Skip to content

The Influence of Paracentesis on Intra-abdominal Pressure and Kidney Function in Critically Ill Patients With Liver Cirrhosis and Ascites: an Observational Study

The Influence of Paracentesis on Intra-abdominal Pressure and Kidney Function in Critically Ill Patients With Liver Cirrhosis and Ascites: an Observational Study

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01091233
Enrollment
0
Registered
2010-03-23
Start date
2010-03-31
Completion date
2012-12-31
Last updated
2021-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically Ill, Liver Cirrhosis, Ascites

Keywords

Critically ill patients, liver cirrhosis, ascites requiring Paracentesis

Brief summary

Patients with liver cirrhosis are at risk for development of renal failure, usually after a precipitating event such as infection or bleeding. This form of renal failure has a high morbidity and mortality and may be partly caused by increased intra-abdominal pressure secondary to ascites. Recent studies have shown that paracentesis (and the resulting decreased IAP) can increase urinary output and decrease renal arterial resistive index in patients with hepatorenal syndrome (a very pronounced form of renal failure in cirrhosis patients). The aim of this study is to evaluate the influence of Paracentesis on intra-abdominal pressure and kidney function in critically ill patients with liver cirrhosis and ascites across a wider range of kidney function. Kidney function will be evaluated using several estimates of glomerular filtration rate and measures of kidney injury i.e. cystatin C, serum NGAL, creatinine clearance, urinary output and renal arterial resistive index.

Interventions

PROCEDUREparacentesis

as indicated according to the treating physician (the indication for Paracentesis is not the subject of study)

Sponsors

University Hospital, Ghent
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \>18 y old * Admitted to the ICU * Known liver cirrhosis with ascites on clinical examination and/or ultrasound * Sedated and mechanically ventilated * Paracentesis deemed necessary by treating physician * Arterial and central venous catheter in place * Urinary catheter in place

Exclusion criteria

* Previous inclusion in the same study * Renal replacement therapy in place * Urinary catheter contra-indicated * Use of radiocontrast media within 72h before paracentesis

Design outcomes

Primary

MeasureTime frameDescription
Intra-abdominal pressure and kidney function before, during, immediately after and 12-24h after Paracentesis24h after paracentesisKidney function parameters include 2h creatinine clearance, serum and urine creatinine, renal artery resistive index (measured via color Doppler), urinary output, serum cystatine C and NGAL measurement.

Secondary

MeasureTime frame
The association between the change in IAP and kidney function24h after paracentesis
The relationship between the amount of fluid drained and any effect on IAP and kidney function24h after paracentesis
Cystatin C, NGAL, creatinine clearance, serum creatinine, urinary output and RI as measures of kidney injury in patients with liver cirrhosis and ascites24h after paracentesis

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026